Ulf Diczfalusy
Department of Laboratory Medicine
Division of Clinical Chemistry
Karolinska Institutet
Stockholm
Sweden
Name/email consistency: high
- 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. Diczfalusy, U., Nylén, H., Elander, P., Bertilsson, L. Br. J. Clin. Pharmacol (2011)
- 4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin. Diczfalusy, U., Kanebratt, K.P., Bredberg, E., Andersson, T.B., Böttiger, Y., Bertilsson, L. Br. J. Clin. Pharmacol (2009)
- 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. Diczfalusy, U., Miura, J., Roh, H.K., Mirghani, R.A., Sayi, J., Larsson, H., Bodin, K.G., Allqvist, A., Jande, M., Kim, J.W., Aklillu, E., Gustafsson, L.L., Bertilsson, L. Pharmacogenet. Genomics (2008)









